193 related articles for article (PubMed ID: 26548585)
21. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
[TBL] [Abstract][Full Text] [Related]
22. Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
Desmonde S; Goetghebuer T; Thorne C; Leroy V
Curr Opin HIV AIDS; 2016 Sep; 11(5):465-476. PubMed ID: 27716731
[TBL] [Abstract][Full Text] [Related]
23. Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth.
Wang Y; Brummel SS; Beilstein-Wedel E; Dagnall CL; Hazra R; Kacanek D; Chadwick EG; Marsit CJ; Chanock SJ; Savage SA; Poirier MC; Machiela MJ; Engels EA;
AIDS; 2019 Nov; 33(13):2091-2096. PubMed ID: 31335808
[TBL] [Abstract][Full Text] [Related]
24. Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.
Jacobson DL; Patel K; Williams PL; Geffner ME; Siberry GK; DiMeglio LA; Crain MJ; Mirza A; Chen JS; McFarland E; Kacanek D; Silio M; Rich K; Borkowsky W; Van Dyke RB; Miller TL;
Pediatr Infect Dis J; 2017 Feb; 36(2):189-197. PubMed ID: 27798548
[TBL] [Abstract][Full Text] [Related]
25. Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children.
Himes SK; Wu JW; Jacobson DL; Tassiopoulos K; Hazra R; Kacanek D; Van Dyke RB; Rich KC; Siberry GK; Huestis MA;
Pediatr Infect Dis J; 2015 Aug; 34(8):851-7. PubMed ID: 25961889
[TBL] [Abstract][Full Text] [Related]
26. Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.
Kirmse B; Hobbs C; Aaron L; Montepiedra G; Summar M; Williams PL; Smith CJ; Van Dyke R; Yu C; Ryckman KK; Borkowsky W;
Pediatr Infect Dis J; 2022 Aug; 41(8):e306-e311. PubMed ID: 35622436
[TBL] [Abstract][Full Text] [Related]
27. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
[TBL] [Abstract][Full Text] [Related]
28. Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
M le Roux S; Jao J; Brittain K; Phillips TK; Olatunbosun S; Ronan A; Zerbe A; Abrams EJ; Myer L
AIDS; 2017 Jan; 31(1):97-104. PubMed ID: 27898591
[TBL] [Abstract][Full Text] [Related]
29. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
[TBL] [Abstract][Full Text] [Related]
30. Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding.
Ngoma MS; Hunter JA; Harper JA; Church PT; Mumba S; Chandwe M; Côté HC; Albert AY; Smith ML; Selemani C; Sandstrom PA; Bandenduck L; Ndlovu U; Khan S; Roa L; Silverman MS
AIDS; 2014 Jul; 28 Suppl 3():S323-30. PubMed ID: 24991905
[TBL] [Abstract][Full Text] [Related]
31. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
32. Distinct cord blood C-peptide, adipokine, and lipidomic signatures by in utero HIV exposure.
Jao J; Balmert LC; Sun S; Qiu Y; Kraus TA; Kirmse B; Sperling RS; Abrams EJ; Myer L; Arpadi S; Geffner ME; LeRoith D; Kurland IJ
Pediatr Res; 2022 Jul; 92(1):233-241. PubMed ID: 34446848
[TBL] [Abstract][Full Text] [Related]
33. Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort.
Wedderburn CJ; Groenewold NA; Roos A; Yeung S; Fouche JP; Rehman AM; Gibb DM; Narr KL; Zar HJ; Stein DJ; Donald KA
J Int AIDS Soc; 2022 Jan; 25(1):e25863. PubMed ID: 35041774
[TBL] [Abstract][Full Text] [Related]
34. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
[TBL] [Abstract][Full Text] [Related]
35. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
[TBL] [Abstract][Full Text] [Related]
36. Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy.
Laughton B; Cornell M; Kidd M; Springer PE; Dobbels EFM; Rensburg AJV; Otwombe K; Babiker A; Gibb DM; Violari A; Kruger M; Cotton MF
J Int AIDS Soc; 2018 May; 21(5):e25106. PubMed ID: 29722482
[TBL] [Abstract][Full Text] [Related]
37. Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort.
Sevenoaks T; Wedderburn CJ; Donald KA; Barnett W; Zar HJ; Stein DJ; Naudé PJW
Brain Behav Immun; 2021 Jan; 91():65-73. PubMed ID: 32860940
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications.
Smith ML; Puka K; Sehra R; Read SE; Bitnun A
AIDS Care; 2017 Oct; 29(10):1302-1308. PubMed ID: 28482682
[TBL] [Abstract][Full Text] [Related]
39. Disclosing
Jao J; Hazra R; Mellins CA; Remien RH; Abrams EJ
J Int AIDS Soc; 2016; 19(1):21099. PubMed ID: 27741954
[TBL] [Abstract][Full Text] [Related]
40. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
